3,3′-Diindolylmethane increases bone mass by suppressing osteoclastic bone resorption in mice

被引:16
作者
Yu, Tai-yong [1 ,2 ]
Pang, Wei-jun [3 ]
Yang, Gong-she [3 ]
机构
[1] Ehime Univ, Grad Sch Med, Proteosci Ctr, Div Integrat Pathophysiol, Toon, Ehime 7910295, Japan
[2] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Epigenet Skeletal Dis, Tokyo 1130032, Japan
[3] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi Provinc, Peoples R China
基金
日本学术振兴会;
关键词
3,3 '-Diindolylmethane (DIM); Bone metabolism; Bone resorption; Osteoporosis; Ovariectomized (OVX); ARYL-HYDROCARBON RECEPTOR; PROSTATE-CANCER; DOWN-REGULATION; IN-VITRO; INDOLE-3-CARBINOL; ACTIVATION; APOPTOSIS; RESVERATROL; INHIBITION; INDUCTION;
D O I
10.1016/j.jphs.2014.11.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
3,3'-Diindolylmethane (DIM), a major acid-condensation product or metabolite of indole-3-carbinol which is found in cruciferous vegetables, has been shown to have anticancer, anti-inflammatory, and multiple immune stimulating effects. However, its function in bone metabolism is poorly understood. This study evaluated the effect of DIM on bone mass in mice under physiological and pathological conditions. Eight-week-old female mice received injections of a vehicle or 0.1 mg/g of DIM, twice a week for four weeks. We found that DIM treatment significantly increased bone mass as assessed by dual-energy X-ray absorptiometry (DEXA) and micro-computed tomography (ACT). Further, Bone histomorphometric analyses showed that this treatment significantly reduced bone resorption parameters, but did not increase bone formation parameters. Furthermore, we use ovariectomized (OVX)-induced osteoporotic mouse model, and explore function of DIM in skeletal pathological processes. Bone phenotype analyses revealed that the administration of DIM in this study effectively prevented OVX-induced bone loss resulting from increased bone resorption. Our results demonstrated that DIM increased bone mass by suppressing osteoclastic bone resorption in bone metabolism under both physiological and pathological conditions. Accordingly. DIM may be of value in the treatment and the possible prevention of bone diseases characterized by bone loss, such as postmenopausal osteoporosis. (C) 2014 Japanese Pharmacological Society. Production and hosting by Elsevier B.V.
引用
收藏
页码:75 / 82
页数:8
相关论文
共 55 条
  • [51] Vitamin D Receptor in Osteoblasts Is a Negative Regulator of Bone Mass Control
    Yamamoto, Yoko
    Yoshizawa, Tatsuya
    Fukuda, Toru
    Shirode-Fukuda, Yuko
    Yu, Taiyong
    Sekine, Keisuke
    Sato, Takashi
    Kawano, Hirotaka
    Aihara, Ken-ichi
    Nakamichi, Yuko
    Watanabe, Tomoyuki
    Shindo, Masayo
    Inoue, Kazuki
    Inoue, Erina
    Tsuji, Naoya
    Hoshino, Maiko
    Karsenty, Gerard
    Metzger, Daniel
    Chambon, Pierre
    Kato, Shigeaki
    Imai, Yuuki
    [J]. ENDOCRINOLOGY, 2013, 154 (03) : 1008 - 1020
  • [52] Curcumin improves bone microarchitecture and enhances mineral density in APP/PS1 transgenic mice
    Yang, Mao-Wei
    Wang, Tong-Hao
    Yan, Pei-Pei
    Chu, Li-Wei
    Yu, Jiang
    Gao, Zhi-Da
    Li, Yuan-Zhou
    Guo, Bao-Lei
    [J]. PHYTOMEDICINE, 2011, 18 (2-3) : 205 - 213
  • [53] A selective aryl hydrocarbon receptor modulator 3,3′-Diindolylmethane inhibits gastric cancer cell growth
    Yin, Xiao-Fei
    Chen, Jie
    Mao, Wei
    Wang, Yu-Hong
    Chen, Min-Hu
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2012, 31
  • [54] Aryl hydrocarbon receptor catabolic activity in bone metabolism is osteoclast dependent in vivo
    Yu, Tai-yong
    Kondo, Takeshi
    Matsumoto, Takahiro
    Fujii-Kuriyama, Yoshiaki
    Imai, Yuuki
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 450 (01) : 416 - 422
  • [55] Skeletal remodeling in health and disease
    Zaidi, Mone
    [J]. NATURE MEDICINE, 2007, 13 (07) : 791 - 801